Hypoxia inducible factor-1α (HIF-1α) and matrix metalloproteinase 9 (MMP-9) expression in invasive breast cancer.

Hypoxia inducible factor-1α (HIF-1α) and matrix metalloproteinase 9 (MMP-9) expression in invasive breast cancer.

Anastasios D Papanastasiou, Haralabos Papatheodorou, Natassa Alexandrou, Foteini Zafeiropoulou, Michalis Leotsinidis, Maria Repanti, Helen Papadaki

Abstract


Aim: Hypoxia has a key role in cancer progression and metastasis. Low tissue oxygen availability induces the activity of HIFs (Hypoxia-Inducible Factors) to up-regulate a panel of invasion related genes, in a plethora of solid tumors. MMPs (matrix metalloproteinases) are enzymes produced from normal and cancerous cells with the ability to degrade extracellular stroma, priming invasion. The aim of this study was to identify possible gene and protein associations between HIF-1α and MMP-9 in invasive breast cancer.

Materials and Methods: A total of 96 FFPE (Formalin-Fixed Paraffin-Embedded) breast cancer samples were evaluated for HIF-1α and MMP-9 protein expression. Publicly available gene expression datasets for breast cancer were analyzed for HIF-1a and MMP-9 gene expression. Results were correlated with clinicopathological parameters and patient clinical outcome.

Results: MMP-9 and HIF-1α showed a positive correlation both at the mRNA (p<0.001) and protein (p=0.01) expression levels, in samples from breast cancer patients. This correlation was specific because HIF-2b, another member of the HIF family, presented with a negative correlation with MMP-9 gene expression. Furthermore, mRNA and protein expression of MMP-9 had a negative correlation (p<0.01) with relapse-free survival (RFS) and a positive correlation (p<0.01) with lymph node status (N1), respectively. In addition, patients with high mRNA expression of HIF-1α had significantly (p<0.001) shorter OS and RFS than did patients with low levels of HIF-1a.

Conclusions: HIF-1α and MMP-9 co-expression may represent a novel marker of worse clinical outcome in breast cancer patients, predicting increased metastatic capacity of cancer cells.


Keywords


Breast Ca, HIF1-alpha, MMP-9

Full Text:

READ AS PDF

References


Koumenis K (et al.) (Eds). Tumor Microenvironment and Cellular Stress. Adv Exp Med Biol. 2014;772:v-viii.

Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93(4):266-76.

Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2(1):38-47.

Cairns RA, Khokha R, Hill RP. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med. 2003;3(7):659-71.

Pouysségur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature. 2006;441(7092):437-43.

Büchler P, Reber HA, Lavey RS, Tomlinson J, Büchler MW, Friess H, Hines OJ. Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model. J Surg Res. 2004;120(2):295-303.

De Bock K, Mazzone M, Carmeliet P. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? Nat Rev Clin Oncol. 2011;8(7):393-404.

Singleton DC, Rouhi P, Zois CE, Haider S, Li JL, Kessler BM, Cao Y, Harris AL. Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasis. Oncogene. 2015;34(36):4713-22.

Dales JP, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut MN, et al. Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer. 2005;116(5):734-9.

Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, et al. Overexpression of hypoxia-inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 2002;8(6):1831-7.

Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, et al. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat. 2008;110(3):465-75.

Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res. 1996;56(22):5279-84.

Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis. 1999;17(2):177-81.

Papatheodorou H, Papanastasiou AD, Sirinian C, Scopa C, Kalofonos HP, Leotsinidis M, et al. Expression patterns of SDF1/CXCR4 in human invasive breast carcinoma and adjacent normal stroma: correlation with tumor clinicopathological parameters and patient survival. Pathol Res Pract. 2014;210(10):662-7.

Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res Treatment. 2010;123(3):725-31


Refbacks

  • There are currently no refbacks.



Copyright 2015-2017, Hellenic Society of Pathology
ISSN: 2459-3443